Valiant Laboratories

Valiant Laboratories Gross Margin

The Gross Margin of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 11.48 %. In the previous year, Gross Margin was 16.00 % — a change of -28.26% (lower).

Gross Margin

11.48 %

YoY

-28.26%

Last updated:

Gross Margin of Valiant Laboratories is 2026 11.48 % . Gross Margin of Valiant Laboratories was 2025 16.00 % . It decreases by -28.26% lower compared to the previous year.

For Valiant Laboratories, the gross margin of 11.5% is down versus 17.9% a few years ago.

The Valiant Laboratories Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2021
32.02 INR
Jan 1, 2022
17.95 INR
Jan 1, 2023
11.68 INR
Jan 1, 2024
6.36 INR
Jan 1, 2025
16.00 INR
Jan 1, 2026
11.48 INR
The Valiant Laboratories Gross Margin history
YEARGross MarginYoY
11.48 %-28.26%
16.00 %+151.71%
6.36 %-45.57%
11.68 %-34.91%
17.95 %-43.94%
32.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Gross Margin of Valiant Laboratories is 11.48 % in 2026.

Gross Margin of Valiant Laboratories changed from 16.00 % to 11.48 %, representing a -28.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Valiant Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Valiant Laboratories

All Key Metrics — Valiant Laboratories